Magnetic resonance imaging and transvaginal ultrasound for determining fibroid burden: implications for research and clinical care

American Journal of Obstetrics and Gynecology

Volumn 200, Issue 5, 2009, Pages 537.e1-537.e7

  Levens, Eric D ^a   Wesley, Robert ^b   Premkumar, Ahalya ^b   Blocker, Wendy ^a   Nieman, Lynnette K ^a  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

detection; imaging; magnetic resonance imaging; ultrasound; uterine fibroids

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; HYSTERECTOMY; INTERMETHOD COMPARISON; KAPPA STATISTICS; MEASUREMENT; MEASUREMENT ERROR; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TRANSVAGINAL ECHOGRAPHY; TUMOR VOLUME; UTERUS MYOMA;

EID: 64249110556     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2008.12.037     Document Type: Article

References (13)

1. Somigliana E., Vercellini P., Daguati R., et al. Fibroids and female reproduction: a critical analysis of the evidence. Hum Reprod Update 13 (2007) 465-476
2. Volkers N.A., Hehenkamp W.J., Spijkerboer A.M., et al. MR reproducibility in the assessment of uterine fibroids for patients scheduled for uterine artery embolization. Cardiovasc Intervent Radiol 31 (2008) 260-268
3. Zawin M., McCarthy S., Scoutt L.M., and Comite F. High-field MRI and US evaluation of the pelvis in women with leiomyomas. Magn Reson Imaging 8 (1990) 371-376
4. Dueholm M., Lundorf E., Hansen E.S., Ledertoug S., and Olesen F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril 76 (2001) 350-357
5. Dueholm M., Lundorf E., Sorensen J.S., Ledertoug S., Olesen F., and Laursen H. Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imaging. Hum Reprod 17 (2002) 195-200
6. Dudiak C.M., Turner D.A., Patel S.K., Archie J.T., Silver B., and Norusis M. Uterine leiomyomas in the infertile patient: preoperative localization with MR imaging versus US and hysterosalpingography. Radiology 167 (1988) 627-630
7. Dueholm M., Lundorf E., Hansen E.S., Ledertoug S., and Olesen F. Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas. Am J Obstet Gynecol 186 (2002) 409-415
8. Levens E.D., Potlog-Nahari C., Armstrong A.Y., et al. CDB-2914 for uterine leiomyomata treatment: a randomized controlled trial. Obstet Gynecol 111 (2008) 1129-1136
9. Bajekal N., and Li T.C. Fibroids, infertility and pregnancy wastage. Hum Reprod Update 6 (2000) 614-620
10. Broekmans F.J., Heitbrink M.A., Hompes P.G., Schoute E., Falke T., and Schoemaker J. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response. Magn Reson Imaging 14 (1996) 1127-1135
11. Fleiss J.L., Levin B.A., and Paik M.C. Statistical methods for rates and proportions: Wiley series in probability and statistics (2003), John Wiley, Hoboken, NJ
12. Parker W.H. Etiology, symptomatology, and diagnosis of uterine myomas. Fertil Steril 87 (2007) 725-736
13. Vitiello D., and McCarthy S. Diagnostic imaging of myomas. Obstet Gynecol Clin North Am 33 (2006) 85-95